Menu Close

Trending

BMS adds to IBD pipeline with $1.9bn GentiBio deal
Eisai steps up beyond-the-pill approach to dementia in Japan
AZ and Daiichi’s TROP2 ADC shows promise in first-line lung cancer
Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance
Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares

Cara Therapeutics

chronic kidney disease

Market Access/ News/ News

Cara, Vifor get EU okay for drug to treat itching in dialysis patients

, , , , , , 0 Comment

Vifor Pharma and Cara Therapeutics’ Kapruvia has become the first drug to be approved in the EU to

X
Cara, Vifor get EU okay for drug to treat itching in dialysis patients
https://pharmaphorum.com/news/cara-vifor-get-eu-okay-for-drug-to-treat-itching-in-dialysis-patients/
Korsuva_image

Market Access/ News/ News

Cara’s Korsuva is first drug cleared for itching in dialysis patients

, , , , , , , 0 Comment

One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease –

X
Cara’s Korsuva is first drug cleared for itching in dialysis patients
https://pharmaphorum.com/news/caras-korsuva-is-first-drug-cleared-for-itching-in-dialysis-patients/

Login

CONTINUE TO SITE >
X
Close in 10 seconds